| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 10 Jan 25 | CRNX Crinetics Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 40.59 | 100,000 | 4.06 mm | 100,000 |
| 12 Feb 24 | IMGN Immunogen | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 19,458 | 0.00 | 0 |
| 12 Feb 24 | IMGN Immunogen | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 47,375 | 0.00 | 0 |
| 12 Feb 24 | IMGN Immunogen | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.39 | 284,250 | 1.53 mm | 0 |
| 1 Feb 24 | IMGN Immunogen | RSU Common Stock | Grant | Acquire A | No | No | 0 | 19,458 | 0.00 | 19,458 |
